Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Fouquet (Lille Cedex, France), J. Giovannelli (Lille Cedex, France), P. De Nadaï (Lille Cedex, France), J. Balsamelli (Lille Cedex, France), P. Berger (BordeauxCedex, France), A. Bourdin (Montpellier, France), P. Chanez (Marseille, France), S. Fry (Lille Cedex, France), T. Perez (Lille Cedex, France), A. Magnan (Nantes, France), M. Pretolani (Paris Cedex, France), C. Taillé (Paris, France), A. Tsicopoulos (Lille Cedex, France), C. Chenivesse (Lille Cedex, France). Is CCL18 a potential biomarker of type-2 asthma?. 1116

Member's Comments

No comment yet.

Related content which might interest you: Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 Year: 2018 Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020 Year: 2021 Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target Source: Eur Respir Rev, 29 (155) 190102; 10.1183/16000617.0102-2019 Year: 2020 Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016 Year: 2017 Leptin as a specific marker of risk factors in severe bronchial asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Lipocalin-2: a biomarker potentially associated with predisposition to COPD Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Visfatin as a possible serum biomarker in COPD Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD Source: Eur Respir J 2014; 43: 951-953 Year: 2014 eNose breathprints as surrogate biomarkers for classifying asthma patients by atopy Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 The role of airways 17ß-estradiol as a biomarker of severity in post-menopausal asthma Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020 Immunoproteasome function as a potential biomarker for asthma severity and response to therapy Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021 Increased serum IL-17 does not predict future risk and impairment in asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Th-17 cytokine profile in a Greek asthmatic population. Correlation with asthma severity and biomarkers of inflammation. Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 The role of Hs-CRP in evaluating asthma severity and asthma control Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Interleukin-18 and interleukin-18 receptor-? expression in allergic asthma Source: Eur Respir J 2011; 38: 981-983 Year: 2011 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 The investigation of the role of interleukin (IL)-17 in COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Does obesity affects circulating inflammatory cytokines in asthmatic children? Source: Annual Congress 2009 - Epidemiology and risk factors of childhood asthma: what every clinician should know Year: 2009